CS250229B2 - Method of 3,4-diamino-1,2,5-thiadiazole derivatives' production - Google Patents

Method of 3,4-diamino-1,2,5-thiadiazole derivatives' production Download PDF

Info

Publication number
CS250229B2
CS250229B2 CS832191A CS219183A CS250229B2 CS 250229 B2 CS250229 B2 CS 250229B2 CS 832191 A CS832191 A CS 832191A CS 219183 A CS219183 A CS 219183A CS 250229 B2 CS250229 B2 CS 250229B2
Authority
CS
Czechoslovakia
Prior art keywords
thiadiazole
amino
propylamino
give
oxide
Prior art date
Application number
CS832191A
Other languages
Czech (cs)
English (en)
Inventor
Ronnie Crenshaw
Aldo A Algieri
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CS250229B2 publication Critical patent/CS250229B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CS832191A 1982-03-29 1983-03-29 Method of 3,4-diamino-1,2,5-thiadiazole derivatives' production CS250229B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29

Publications (1)

Publication Number Publication Date
CS250229B2 true CS250229B2 (en) 1987-04-16

Family

ID=23429274

Family Applications (2)

Application Number Title Priority Date Filing Date
CS832191A CS250229B2 (en) 1982-03-29 1983-03-29 Method of 3,4-diamino-1,2,5-thiadiazole derivatives' production
CS841958A CS250240B2 (en) 1982-03-29 1983-03-29 Method of ethandiimidamide's derivatives production

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS841958A CS250240B2 (en) 1982-03-29 1983-03-29 Method of ethandiimidamide's derivatives production

Country Status (30)

Country Link
JP (2) JPS58180477A (de)
KR (1) KR880002209B1 (de)
AT (1) AT386599B (de)
AU (2) AU557577B2 (de)
BE (1) BE896291A (de)
CH (2) CH660880A5 (de)
CS (2) CS250229B2 (de)
DD (2) DD219768A5 (de)
DE (1) DE3311281A1 (de)
DK (2) DK166677B1 (de)
ES (3) ES8404683A1 (de)
FR (2) FR2542741B1 (de)
GB (2) GB2117769B (de)
GR (1) GR78524B (de)
HU (2) HU196386B (de)
IE (1) IE55596B1 (de)
IL (1) IL68259A0 (de)
IT (1) IT1164633B (de)
LU (1) LU84716A1 (de)
MY (1) MY8700942A (de)
NL (1) NL8301063A (de)
NO (1) NO163055C (de)
NZ (1) NZ203726A (de)
OA (1) OA07356A (de)
PT (1) PT76459B (de)
SE (2) SE461040B (de)
SU (2) SU1419518A3 (de)
YU (1) YU44849B (de)
ZA (1) ZA832154B (de)
ZW (1) ZW7683A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (ja) * 1986-06-30 1994-03-30 フアナツク株式会社 直圧式型締機構
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
DD210909A5 (de) 1984-06-27
JPS58180477A (ja) 1983-10-21
ES8505978A1 (es) 1985-06-16
DK81192A (da) 1992-06-18
ES8505977A1 (es) 1985-06-16
NO163055C (no) 1990-03-28
NZ203726A (en) 1986-05-09
GR78524B (de) 1984-09-27
GB2117769B (en) 1985-08-29
IE830686L (en) 1983-09-29
YU74483A (en) 1986-02-28
ES520982A0 (es) 1984-05-16
LU84716A1 (fr) 1983-12-05
KR840004095A (ko) 1984-10-06
SE8301725D0 (sv) 1983-03-28
ZA832154B (en) 1983-12-28
GB8308518D0 (en) 1983-05-05
SE8301725L (sv) 1983-11-25
SE8704689L (sv) 1987-11-25
PT76459A (en) 1983-04-01
OA07356A (fr) 1984-08-31
HU196386B (en) 1988-11-28
SE464302B (sv) 1991-04-08
DK141383D0 (da) 1983-03-28
SE461040B (sv) 1989-12-18
AT386599B (de) 1988-09-12
BE896291A (fr) 1983-09-28
IT8348005A0 (it) 1983-03-28
CH655111A5 (de) 1986-03-27
SU1355123A3 (ru) 1987-11-23
JPH0568472B2 (de) 1993-09-29
CH660880A5 (de) 1987-05-29
HU188742B (en) 1986-05-28
SU1419518A3 (ru) 1988-08-23
IT1164633B (it) 1987-04-15
DE3311281A1 (de) 1983-11-24
ATA111083A (de) 1988-02-15
ZW7683A1 (en) 1984-01-04
KR880002209B1 (ko) 1988-10-18
DK81192D0 (da) 1992-06-18
AU6327286A (en) 1987-01-08
FR2597867A1 (fr) 1987-10-30
PT76459B (en) 1986-03-11
GB2117769A (en) 1983-10-19
FR2597867B1 (fr) 1989-12-08
ES527685A0 (es) 1985-06-16
AU557577B2 (en) 1986-12-24
AU1290783A (en) 1983-10-06
YU44849B (en) 1991-04-30
NO831100L (no) 1983-09-30
MY8700942A (en) 1987-12-31
GB2149406A (en) 1985-06-12
FR2542741A1 (fr) 1984-09-21
IE55596B1 (en) 1990-11-21
FR2542741B1 (fr) 1989-12-08
AU586037B2 (en) 1989-06-29
GB8432809D0 (en) 1985-02-06
ES527686A0 (es) 1985-06-16
ES8404683A1 (es) 1984-05-16
NO163055B (no) 1989-12-18
SE8704689D0 (sv) 1987-11-25
CS250240B2 (en) 1987-04-16
DK166677B1 (da) 1993-06-28
DD219768A5 (de) 1985-03-13
DK141383A (da) 1983-09-30
JPH06135925A (ja) 1994-05-17
IL68259A0 (en) 1983-06-15
GB2149406B (en) 1986-01-02
NL8301063A (nl) 1983-10-17

Similar Documents

Publication Publication Date Title
JPH0251425B2 (de)
CS207790B2 (en) Method of making the derivatives of the thiadiazole
FI79848B (fi) Nytt foerfarande foer framstaellning av histamin-h2-antagonistiska 3-(amino eller substituerad amino)-4- (substituerad amino)-1,2,5-tiadiazoler.
FI90869C (fi) Menetelmä lääkeaineena käyttökelpoisten imidatsolidinonijohdannaisten valmistamiseksi
CS272783B2 (en) Method of arylpiperazinyl-alkylenphenyl-heterocyclic compounds production
CS250229B2 (en) Method of 3,4-diamino-1,2,5-thiadiazole derivatives' production
KR870000912B1 (ko) 디하이드로피리딘 유도체의 제조방법
US4528375A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPS6330903B2 (de)
US4528378A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4600779A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528377A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4588826A (en) Ethanediimidamide intermediates
US4578471A (en) Substituted amino alkyl pyridyl ethanediimidamides
KR900004321B1 (ko) 히스타민 h_2-섭수체 길항작용을 가진 치환 3,4-디아미노-1,2,5-티아디아졸류 및 그 제조방법
KR880002530B1 (ko) 치환된 에탄디이미드 아미드 및 그의 제조방법
US4517366A (en) Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
US4595758A (en) Ethanediimidamide intermediates
EP0081955A2 (de) Benzo-Kondensierte heterocyclische Derivate
EP0452076A1 (de) Thiazol- und Imidazolderivate und Zusammensetzungen gegen Magengeschwüre, die sie enthalten
NO880872L (no) Fremgangsmaate til fremstilling av en kjemisk forbindelse.
US3956325A (en) 5-Heterocyclic-1,2,3,6-tetrahydro-4(5H) pyrimidinone
US3910914A (en) 5-Heterocyclic-1,2,3,6-tetrahydro-4(5H)-pyrimidinethiones and pyrimidinone intermediates therefor
KR850000910B1 (ko) 아미노티아디아졸의 제법
CS246052B2 (en) Method of 3,4-disubstituted 1,2,5-thiadiazole-1-oxides and-1,1-dioxides production